bioAffinity Technologies (BIAF) Non-Current Assets (2021 - 2026)
bioAffinity Technologies (BIAF) posted quarterly Non-Current Assets of $3.6 million for Q1 2026, down 2.16% year-over-year from $3.7 million in Q1 2025, and up 6.13% quarter-over-quarter from $3.4 million in Q4 2025.
bioAffinity Technologies (BIAF) Non-Current Assets (2021 - 2026) Analysis & Trends
bioAffinity Technologies (BIAF) has reported Non-Current Assets for 6 consecutive years, with $3.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Non-Current Assets fell 2.16% year-over-year to $3.6 million; the TTM figure through Mar 2026 stood at $13.0 million (down 15.93% YoY), while the FY2025 annual figure was $3.4 million, down 11.08% from the prior year.
- Non-Current Assets advanced to $3.6 million in Q1 2026 per BIAF's latest filing, from $3.4 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $4.2 million in Q4 2023 and bottomed at $7781.0 in Q3 2022.
- Historically, Non-Current Assets has averaged $2.8 million across 5 years, with a median of $3.6 million in 2026.
- Annual changes were most pronounced in 2023 — Non-Current Assets jumped 53611.03% — and 2025, when it decreased 26.73%.
- bioAffinity Technologies' Non-Current Assets stood at $220438.0 in 2022, then surged by 1827.44% to $4.2 million in 2023, then slipped by 10.13% to $3.8 million in 2024, then decreased by 11.08% to $3.4 million in 2025, then climbed by 6.13% to $3.6 million in 2026.
- Business Quant data shows BIAF's Non-Current Assets at $3.6 million in Q1 2026, $3.4 million in Q4 2025, and $2.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 89.81 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 78.99 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 1.93 Bn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 8.30 Bn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 23.66 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 962.59 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 3.82 Bn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 2.32 Bn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 14.10 Bn |
| 10 | bioAffinity Technologies | 2.38 Mn | -721,990.64 | - | 3.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.60 Mn |
| Dec 31, 2025 | 3.40 Mn |
| Sep 30, 2025 | 2.93 Mn |
| Jun 30, 2025 | 3.08 Mn |
| Mar 31, 2025 | 3.68 Mn |
| Dec 31, 2024 | 3.82 Mn |
| Sep 30, 2024 | 4.00 Mn |
| Jun 30, 2024 | 3.98 Mn |
| Mar 31, 2024 | 4.12 Mn |
| Dec 31, 2023 | 4.25 Mn |
| Sep 30, 2023 | 4.18 Mn |
| Jun 30, 2023 | 214,296.00 |
| Mar 31, 2023 | 231,987.00 |
| Dec 31, 2022 | 220,438.00 |
| Sep 30, 2022 | 7,781.00 |
| Dec 31, 2021 | 15,075.00 |